Toradol (ketorolac tromethamine) is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the short-term treatment of moderately severe acute pain that typically requires analgesia at the opioid level. Clinically, it is frequently used after surgical procedures, for acute musculoskeletal injuries, renal colic, and in emergency or urgent care settings where rapid, non-opioid pain control is desired.
Unlike acetaminophen, Toradol provides anti-inflammatory benefits by inhibiting prostaglandin synthesis, which helps reduce pain and swelling. It is not an opioid and does not cause respiratory depression or physical dependence, making it a valuable option in multimodal pain strategies. However, it carries risks characteristic of NSAIDs—particularly gastrointestinal bleeding and kidney effects—so it is reserved for brief courses and specific scenarios, not for chronic or minor pain.
Typical routes include IV or IM injection for rapid onset, oral tablets to continue treatment after initial parenteral dosing, and an intranasal formulation used in some outpatient settings. Most adults experience meaningful relief within minutes to an hour, depending on the route.
Toradol is a time-limited therapy. The combined duration of IV/IM/oral use should not exceed five days in adults due to elevated risks with longer use. Always follow your clinician’s plan; the information below is educational and not a substitute for medical advice.
Injectable dosing (adults under 65 years with normal kidney function): For a single-dose treatment, typical IM dosing is 60 mg once; IV single-dose is often 30 mg. For multiple-dose regimens, 30 mg IV/IM every six hours may be used as needed, not to exceed 120 mg/day. These dosing decisions depend on the clinical situation and clinician judgment.
Reduced dosing is advised for adults aged 65 and older, those under 50 kg (110 lb), or people with renal impairment. In these cases, typical multiple-dose regimens are 15 mg IV/IM every six hours, with a maximum of 60 mg/day. Toradol is generally avoided in significant kidney disease.
Oral dosing: If transitioning from injection, an initial 10 mg oral dose may be followed by 10 mg every four to six hours as needed, up to 40 mg/day. Oral therapy is commonly used to complete the five-day total limit across all routes combined. Take tablets with a full glass of water; taking with food can reduce stomach upset.
Intranasal ketorolac (where available) may be prescribed in select adult patients who need non-oral, non-injection options. Dosing and eligibility vary by product and clinical evaluation.
Key directions: Use the lowest effective dose for the shortest possible duration. Do not combine Toradol with other NSAIDs (e.g., ibuprofen, naproxen) or aspirin for pain relief unless specifically directed. Avoid alcohol while taking Toradol due to increased GI risk. If you develop stomach pain, black stools, vomiting blood, shortness of breath, severe dizziness, or reduced urine output, stop the medication and seek immediate care.
Gastrointestinal risk: Toradol can cause stomach or intestinal bleeding, which may occur without warning. Risk is higher in older adults, smokers, people with a history of ulcers or GI bleeding, and those using anticoagulants, antiplatelet drugs, SSRIs/SNRIs, or corticosteroids. Report any unusual abdominal pain, dark stools, or vomiting blood immediately.
Cardiovascular risk: NSAIDs may increase the risk of heart attack or stroke, particularly with higher doses and longer durations. Toradol is not intended for chronic pain and should not be used around the time of coronary artery bypass graft (CABG) surgery.
Renal considerations: Ketorolac reduces prostaglandins that help maintain kidney blood flow, especially in dehydrated or medically complex patients. People with kidney disease, heart failure, or those taking ACE inhibitors/ARBs and diuretics are at particular risk. Clinicians may monitor kidney function or avoid Toradol altogether in high-risk cases.
Respiratory and allergy concerns: Patients with aspirin-sensitive asthma, nasal polyps, or a history of urticaria/bronchospasm from NSAIDs should not use Toradol due to risk of serious reactions, including anaphylaxis.
Hematologic effects: Toradol can impair platelet function and prolong bleeding time. It is not suitable for patients with active bleeding, bleeding disorders, or inadequate hemostasis. Use caution before or after invasive procedures as directed by your clinician.
Pregnancy and fertility: Avoid Toradol in the third trimester due to the risk of premature closure of the fetal ductus arteriosus and fetal kidney injury. In general, NSAIDs should be avoided after 20 weeks’ gestation unless specifically directed. Toradol is contraindicated during labor and delivery. It may temporarily affect fertility while taken.
Breastfeeding: Small amounts may pass into breast milk. Discuss risks and benefits with your healthcare provider, especially for newborns or preterm infants.
Special populations: Older adults are more susceptible to GI and kidney side effects. Lower starting doses and close monitoring are common. Pediatric use is limited; your clinician will determine appropriateness and dosing if considered.
Do not use Toradol if you have any of the following unless a clinician has explicitly determined it is safe and legal for your situation:
• Active peptic ulcer disease, recent GI bleeding or perforation, or history of recurrent GI bleeding/ulceration
• Known hypersensitivity to ketorolac, aspirin, or other NSAIDs, including individuals with aspirin-exacerbated respiratory disease (asthma, nasal polyps, and rhinitis)
• Advanced renal impairment or those at high risk for renal failure due to volume depletion
• Suspected or confirmed cerebrovascular bleeding, hemorrhagic diathesis, or incomplete hemostasis
• Use as prophylactic analgesic before any major surgery; perioperative pain in CABG surgery
• Labor and delivery
• Concurrent use with other NSAIDs, including high-dose aspirin for pain
• Concomitant use with probenecid or pentoxifylline (increases risk of toxicity or bleeding)
• Intrathecal or epidural administration (contraindicated)
Common side effects include nausea, indigestion, abdominal discomfort, headache, dizziness, drowsiness, and injection-site pain (for IM/IV). These often improve as your body adjusts or as treatment is completed.
Serious adverse effects that require immediate medical attention include signs of stomach or intestinal bleeding (black, tarry stools; vomiting blood or coffee-ground material), severe abdominal pain, fainting, chest pain, shortness of breath, sudden weakness or slurred speech, significant swelling, rapid weight gain, decreased urination, yellowing of the skin or eyes, severe skin rash, and signs of allergic reaction (hives, wheezing, facial or throat swelling).
While rare, anaphylaxis can occur in patients with NSAID allergy. Because Toradol can affect blood clotting, unusual bruising or prolonged bleeding should prompt urgent evaluation. Always report concerning symptoms promptly.
To reduce risk, provide your clinician with a complete medication and supplement list. Notable interactions include:
• Other NSAIDs or salicylates: Increased risk of GI bleeding and kidney effects—avoid combined use for pain
• Anticoagulants (e.g., warfarin), antiplatelets (e.g., clopidogrel, aspirin), SSRIs/SNRIs: Elevated bleeding risk
• Corticosteroids: Higher risk of GI ulceration and bleeding
• ACE inhibitors, ARBs, diuretics: Potential reduction in kidney function; monitor closely
• Lithium and methotrexate: Possible increased serum levels and toxicity; monitoring or alternatives may be necessary
• Probenecid and pentoxifylline: Contraindicated with ketorolac due to increased toxicity/bleeding risk
• Alcohol and tobacco: Heighten GI risks; avoid alcohol while using Toradol and consider GI protection strategies if clinically indicated
Herbal supplements such as ginkgo, garlic, ginseng, or fish oil at high doses may increase bleeding risk. Discuss all nonprescription products with your clinician.
Toradol is often given as needed or on a short, scheduled course. If you miss a scheduled dose and it’s still far from your next dose, take it as soon as you remember. If it’s close to the next dose, skip the missed dose—do not double up to catch up. For clinic-administered injections, contact the clinic to reschedule. Always adhere to the total therapy limit of five days across all formulations unless your clinician provides a different, explicit directive.
Signs of overdose can include severe stomach pain, persistent vomiting, drowsiness, dizziness, GI bleeding, elevated blood pressure, slowed breathing, and reduced urination. Massive ingestions can lead to metabolic acidosis, acute kidney injury, and rarely seizures. If an overdose is suspected, call emergency services or poison control immediately. Early medical care may include activated charcoal if within a short window and supportive monitoring of vital signs, kidney function, and bleeding parameters. Hemodialysis is unlikely to remove ketorolac effectively; management focuses on stabilization and treating complications.
Store Toradol tablets at room temperature in a dry place away from moisture and direct light. Keep vials in accordance with the package insert, protecting from light and extremes of temperature. Do not freeze unless the labeling specifies otherwise. Always keep medications out of reach of children and pets. Do not use beyond the expiration date, and discard any medication that shows discoloration or compromised packaging. If your clinician dispenses single-use vials or prefilled syringes, follow instructions for safe disposal of sharps and unused portions.
In the United States, Toradol (ketorolac) is a prescription-only medication with strict safety limitations, including a maximum recommended duration of five days across all routes and clear contraindications. It is not available over the counter. Any pathway to access Toradol must comply with federal and state regulations and involve clinician oversight to ensure safe, appropriate use.
St. Joseph’s Health offers a legal and structured solution to buy Toradol without a traditional prior prescription, using a clinician-guided care model. Practically, this means you can initiate care without bringing an external prescription; a qualified clinician evaluates your condition—often via same-day in-person or telehealth assessment—and, if appropriate, authorizes Toradol for on-site administration or same-day dispensing. You do not receive Toradol without a clinician’s order; rather, the prescribing step is integrated into the visit, ensuring compliance and safety.
This streamlined access can be invaluable when acute pain strikes and time matters. The St. Joseph’s Health process typically includes eligibility screening, medical history review (including kidney, GI, and cardiovascular risk factors), medication reconciliation for interactions, and counseling on dosing and duration limits. If Toradol is not appropriate, clinicians recommend safer alternatives tailored to your needs.
Key takeaways for U.S. consumers: Toradol is not sold OTC; any legitimate access requires clinician authorization. “Without prescription” in this context means you do not need to obtain a prescription in advance from another provider—St. Joseph’s Health handles the medical evaluation and, when indicated, issues the necessary order and provides the medication through a compliant, patient-centered workflow.
As with any powerful analgesic, use Toradol exactly as directed by your care team, adhere to the five-day therapy limit, and report any warning symptoms immediately. If you have questions about eligibility, costs, or scheduling, contact St. Joseph’s Health for details on their same-day evaluation and dispensing options for acute pain treatment.
Educational note: The information here is general and may not reflect your unique health situation. Always consult with a healthcare professional who can consider your full medical history before using Toradol or any NSAID.
Toradol is the brand name for ketorolac, a nonsteroidal anti-inflammatory drug (NSAID) that blocks COX enzymes to reduce prostaglandins, lowering pain and inflammation without using opioids.
It is prescribed for short‑term management of moderate to severe acute pain, such as postoperative pain, injuries, dental extraction pain, migraines, or kidney stone pain when stronger relief is needed.
IV Toradol can start working within 10–30 minutes, IM and oral usually within 30–60 minutes; relief often lasts 4–6 hours, sometimes up to 8 hours.
Typical adult IV/IM doses are 15–30 mg every 6 hours (lower in adults over 65, low body weight, or renal impairment), and oral dosing is usually 10 mg every 4–6 hours; the total combined duration by any route should not exceed 5 days.
Risk of serious side effects—including stomach ulcers or bleeding and kidney injury—increases sharply with higher doses and longer use, so labeling restricts therapy to the shortest possible time, up to 5 days.
Nausea, stomach upset, heartburn, dizziness, drowsiness, headache, fluid retention, and pain at the injection site are most common; the nasal spray can cause nose or throat irritation.
Seek urgent care for black or bloody stools, vomiting blood, severe stomach pain, shortness of breath or wheezing, swelling or sudden weight gain, very little urine, chest pain, weakness on one side, or unusual bruising or bleeding.
People with active ulcers or recent GI bleeding, advanced kidney disease, aspirin/NSAID allergy or asthma triggered by NSAIDs, bleeding disorders, recent or upcoming CABG surgery, late pregnancy, or those taking other NSAIDs should avoid it.
Avoid during pregnancy, especially after 20 weeks and in the third trimester due to fetal kidney effects and premature ductus arteriosus closure; NSAIDs may temporarily affect ovulation; small amounts enter breast milk, so short‑term use may be considered with medical guidance.
Older adults and those with reduced kidney function have higher risks of bleeding and kidney injury; if used, doses are lower, duration is shorter, and kidney function and hydration should be monitored closely.
Combining with other NSAIDs or aspirin increases GI bleeding risk; anticoagulants, antiplatelets, SSRIs/SNRIs, and corticosteroids raise bleeding risk; ACE inhibitors/ARBs and diuretics increase kidney risk; lithium and methotrexate levels can rise; alcohol and herbs like ginkgo or garlic can add bleeding risk.
It can be combined with acetaminophen for added pain relief, but should not be taken with ibuprofen, naproxen, or other NSAIDs; do not combine with aspirin unless a prescriber specifically instructs you due to bleeding risk.
No, Toradol is a non‑opioid NSAID and is not addictive, but it carries its own serious risks if misused or taken longer than prescribed.
Yes, ketorolac is frequently used in emergency and dental settings for acute migraine, renal colic, and post‑extraction pain, offering strong non‑opioid relief when given by injection or short oral courses.
Alcohol increases the chance of stomach irritation and bleeding with NSAIDs; it’s safest to avoid or minimize alcohol while using Toradol.
It is commonly used after surgery to reduce opioid needs, but surgeons may avoid it where bleeding risk is a concern or after certain procedures; decisions are case‑by‑case.
A common approach is to start with IV/IM doses for rapid relief, then switch to oral 10 mg every 4–6 hours as needed, keeping the total duration of all forms to no more than 5 days.
Like other NSAIDs, it can raise blood pressure and carries a risk of cardiovascular events; people with heart disease or risk factors should discuss safer alternatives.
No, all forms of ketorolac are prescription‑only.
Take oral doses with food, avoid alcohol and smoking, use the lowest effective dose for the shortest time, and ask your clinician if you need a protective agent like a PPI when at higher GI risk.
Toradol is generally more potent and available by injection for moderate to severe acute pain, while ibuprofen is milder, OTC, and better suited for mild to moderate pain or chronic use at the lowest effective dose.
Naproxen’s effects typically last 8–12 hours and it can be used longer term when appropriate, while Toradol provides strong short‑term relief but is limited to 5 days due to higher GI and renal risks.
Diclofenac is effective for musculoskeletal and arthritis pain, comes in oral and topical forms, and is used chronically with caution; Toradol is preferred for brief, intense acute pain or postoperative pain when injection and opioid‑sparing are desired.
Meloxicam is a once‑daily, COX‑2–preferential NSAID used for chronic inflammatory conditions with somewhat better GI tolerability; Toradol is for short‑term acute pain and is not suitable for chronic therapy.
Indomethacin is often chosen for acute gout flares and has established roles there, but it has notable CNS/GI side effects; Toradol can be used for acute headache or severe pain episodes but is not a first‑line gout medication.
Celecoxib is COX‑2 selective and tends to cause fewer GI ulcers than nonselective NSAIDs, making it better for longer use in at‑risk patients; Toradol is stronger acutely but carries higher bleeding risk and is limited to short courses.
No; aspirin at low dose is used for heart protection due to irreversible platelet inhibition, while Toradol is for short‑term pain relief; they should not be combined without medical direction due to bleeding risk.
Both are effective IV NSAIDs; Toradol often provides brisk analgesia with strong opioid‑sparing effects, whereas IV ibuprofen may be gentler on platelets and is also antipyretic; choice depends on bleeding, kidney, and cardiovascular risk profiles.
Nabumetone, a prodrug with relative GI sparing, is used for chronic conditions; Toradol delivers stronger short‑term pain relief but has higher GI and renal risks and must be limited to brief use.
Both are nonselective NSAIDs; ketoprofen is typically oral and used for mild to moderate pain or inflammation, while Toradol offers potent acute analgesia including parenteral routes but is restricted to 5 days.
Etodolac has some COX‑2 preference and may be better tolerated in the GI tract for longer-term use; Toradol is reserved for short, intense pain episodes with higher bleeding and renal risk if extended.
Topical diclofenac is best for localized soft‑tissue or joint pain with minimal systemic exposure; Toradol is systemic and appropriate for widespread or severe acute pain when topical therapy is inadequate.
Injected or intranasal ketorolac can act faster and more strongly in the emergency setting, while oral naproxen may help milder attacks or as part of a home regimen; preventive migraine care requires different medications.
For a sudden severe flare, a short course of Toradol may provide rapid relief; for ongoing inflammatory back pain, meloxicam is more appropriate due to once‑daily dosing and better suitability for longer use.
For a localized sprain, diclofenac gel offers pain relief with far less systemic risk; Toradol is systemic and generally reserved for more severe pain that doesn’t respond to local measures.
